ENVISIA THERAPEUTICS TO PRESENT NEW DATA AT ARVO 2017 ANNUAL MEETING

ENVISIA THERAPEUTICS TO PRESENT NEW DATA AT ARVO 2017 ANNUAL MEETING

Company to Deliver Seven Data Presentations at World’s Largest International Ophthalmology Gathering

RESEARCH TRIANGLE PARK, NC May 5, 2017 – Envisia Therapeutics today announced that the Company will present new data for its next generation product candidate, ENV515 for glaucoma, as well as new data from its back of the eye programs, at the Association for Research in Vision and Ophthalmology’s (ARVO) Annual Meeting being held May 7-11, 2017 in Baltimore, MD.  Read more here.

Copyright 2013 Envisia Therapeutics